LifeScience
Aspen Neuroscience Secures $115 Million Series C to Advance Personalised Cell Therapy for Parkinson’s Disease
Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, announced the closing of a $115 millio...
November 21, 2025 | News
CRScube Acquires Mednet to Build a Unified Global eClinical Platform Across Asia and North America
CRScube has announced the successful acquisition of Mednet, marking a key milestone in its global strategic growth and expansion into the North Ameri...
November 20, 2025 | News
Nona Biosciences Enters License Agreement with Pfizer to Advance Global Antibody Discovery
Nona Biosciences, a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I® (Idea t...
November 20, 2025 | News
Tsingke Biotech Showcases Breakthrough Speed in Protein and Antibody Development at PEGS Europe 2025
At PEGS Europe 2025, one of the industry's premier gatherings for innovation in protein and antibody engineering, Tsingke Biotech highlighted its latest ac...
November 20, 2025 | News
YolTech Therapeutics Receives FDA Clearance to Begin Pivotal Trial for In Vivo Gene Editing Therapy in PH1
YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today announced that the U.S. Food ...
November 20, 2025 | News
Apriori Bio and A STAR IDL Launch Strategic Partnership to Co Develop Next Generation saRNA Vaccines for Seasonal and Pandemic Influenza
Apriori Bio, a Flagship Pioneering company focused on developing prospective, variant-resilient vaccines, and the Agency for Science, Technology and Resear...
November 19, 2025 | News
Bio Techne Licenses AI Designed NovoBody Duo Molecules Under Exclusive Agreement With Monod Bio
Partnership strengthens Bio-Techne's leadership in AI-enabled protein innovation NovoBody™ Duo molecules offer multi-specific binding capabilities...
November 19, 2025 | News
AbbVie Secures Approval for EPKINLY in Combination With R2 as the First Bispecific Therapy for Relapsed or Refractory Follicular Lymphoma
EPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is now the first and only bispecific antibody combination therapy available f...
November 19, 2025 | News
Genesis MedTech And NUHS Launch AI Innovation Partnership To Advance The Future Of Surgery
Genesis MedTech Group and the National University Health System (NUHS) have formed a strategic partnership to advance artificial intelligence (AI...
November 19, 2025 | News
10x Genomics And ASTRA Consortium Launch Asia Pacific Pan Cancer Spatial Atlas To Advance Precision Oncology
Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across the region 10x Genomi...
November 19, 2025 | News
Terumo BCT Achieves Breakthrough in Automated T Cell Therapy Manufacturing
Terumo Blood and Cell Technologies (Terumo BCT), a global leader in cell and gene therapy technologies, announced an advancement in T cell therapy manufact...
November 19, 2025 | News
Ono Opens New Zug Office to Support Strategic Expansion Across the EMEA Region
Ono Pharmaceutical Co., Ltd. announced the opening of a new 733-square-meter office in Zug, Switzerland, to accommodate the company’s growth in Europ...
November 18, 2025 | News
Volta Labs Expands Callisto Automation Through Strategic Partnership with New England Biolabs
Volta Labs, a leader in automation for genomics, and New England Biolabs® (NEB®), a world-renowned provider of life science reagents,&nb...
November 17, 2025 | News
LISCure Biosciences Secures Fourth Global Evaluation Partner for Its Next Generation BBB Shuttle Platform ExoPN 101
LISCure Biosciences ("LISCure"), a biotechnology company advancing next-generation therapeutics, today announced that it has entered into a new Materi...
November 14, 2025 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
Editor Picks
